These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31846493)

  • 1. Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis.
    Melis M; Littera R; Cocco E; Frau J; Lai S; Congeddu E; Ragatzu P; Serra M; Loi V; Maddi R; Pitzalis R; Orrù S; Chessa L; Perra A; Carcassi C
    PLoS One; 2019; 14(12):e0226615. PubMed ID: 31846493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIRs and their HLA ligands in remitting-relapsing multiple sclerosis.
    Fusco C; Guerini FR; Nocera G; Ventrella G; Caputo D; Valentino MA; Agliardi C; Gallotti J; Morra VB; Florio C; Clerici M; Lombardi ML
    J Neuroimmunol; 2010 Dec; 229(1-2):232-7. PubMed ID: 20826009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
    Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
    Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Human Leukocyte Antigen (HLA) Alleles and Killer Cell Immunoglobulin-Like Receptors (KIR) Types on Heparin-Induced Thrombocytopenia (HIT).
    Karnes JH; Shaffer CM; Cronin R; Bastarache L; Gaudieri S; James I; Pavlos R; Steiner HE; Mosley JD; Mallal S; Denny JC; Phillips EJ; Roden DM
    Pharmacotherapy; 2017 Sep; 37(9):1164-1171. PubMed ID: 28688202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining evidence from four immune cell types identifies DNA methylation patterns that implicate functionally distinct pathways during Multiple Sclerosis progression.
    Ewing E; Kular L; Fernandes SJ; Karathanasis N; Lagani V; Ruhrmann S; Tsamardinos I; Tegner J; Piehl F; Gomez-Cabrero D; Jagodic M
    EBioMedicine; 2019 May; 43():411-423. PubMed ID: 31053557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
    Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
    Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
    Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
    Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection.
    Littera R; Chessa L; Deidda S; Angioni G; Campagna M; Lai S; Melis M; Cipri S; Firinu D; Santus S; Lai A; Porcella R; Rassu S; Meloni F; Schirru D; Cordeddu W; Kowalik MA; Ragatzu P; Vacca M; Cannas F; Alba F; Carta MG; Del Giacco S; Restivo A; Deidda S; Palimodde A; Congera P; Perra R; Orrù G; Pes F; Loi M; Murru C; Urru E; Onali S; Coghe F; Giglio S; Perra A
    PLoS One; 2021; 16(8):e0255608. PubMed ID: 34352002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIR genes and HLA class I ligands in a Caucasian Brazilian population with colorectal cancer.
    Portela P; Merzoni J; Lindenau JD; Damin DC; Wilson TJ; Roesler R; Schwartsmann G; Jobim LF; Jobim M
    Hum Immunol; 2017 Mar; 78(3):263-268. PubMed ID: 28088355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killer cell immunoglobulin-like receptor and human leukocyte antigen gene profiles in a cohort of HIV-infected Mexican Mestizos.
    Garrido-Rodríguez D; Ávila-Ríos S; García-Morales C; Valenzuela-Ponce H; Ormsby C; Reyes-Gopar H; Fernandez-Lopez JC; Reyes-Terán G
    Immunogenetics; 2016 Oct; 68(9):703-17. PubMed ID: 27240860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.
    Symons HJ; Leffell MS; Rossiter ND; Zahurak M; Jones RJ; Fuchs EJ
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):533-42. PubMed ID: 19961944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis by phenotype in Germany.
    Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
    Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer.
    Cornillet M; Jansson H; Schaffer M; Hertwig L; Berglin L; Zimmer CL; Johansson H; Ellis E; Isaksson B; Gonzalez-Galarza FF; Middleton D; Malmberg KJ; Sparrelid E; Björkström NK
    Gastroenterology; 2019 Oct; 157(4):1067-1080.e9. PubMed ID: 31229495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis.
    Jelcić I; Hsu KC; Kakalacheva K; Breiden P; Dupont B; Uhrberg M; Martin R; Münz C; Lünemann JD
    Mult Scler; 2012 Jul; 18(7):951-8. PubMed ID: 22185807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of Polish patients with primary progressive multiple sclerosis.
    Brola W; Sobolewski P; Żak M; Flaga S; Fudala M; Siutka D; Kapica K; Chorąży M; Kułakowska A; Perenc A; Bartosik-Psujek H; Psujek M; Głąbiński A; Pawełczyk M; Gacek S; Potemkowski A
    Mult Scler Relat Disord; 2019 Aug; 33():33-38. PubMed ID: 31146082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.
    Knapp R; Hardtstock F; Krieger J; Wilke T; Maywald U; Chognot C; Muros-Le Rouzic E; Craveiro L
    Mult Scler Relat Disord; 2022 Dec; 68():104245. PubMed ID: 36306609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
    Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
    Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating killer-cell immunoglobulin-like receptors (KIR) and their cognate HLA ligands are significantly increased in autism.
    Torres AR; Westover JB; Gibbons C; Johnson RC; Ward DC
    Brain Behav Immun; 2012 Oct; 26(7):1122-7. PubMed ID: 22884899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
    Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
    J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killer-cell immunoglobulin-like receptor expression on lymphocyte subsets in multiple sclerosis patients treated with interferon-β: evaluation as biomarkers for clinical response.
    García-León JA; López-Gómez C; Orpez-Zafra T; Reyes-Garrido V; Marín-Bañasco C; Oliver-Martos B; Fernández O; Leyva L
    CNS Drugs; 2014 Jun; 28(6):559-70. PubMed ID: 24599774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.